1. | chae69933 | |
2. | heyjosh | |
3. | brianpitkin | |
4. | howpilothero | |
5. | apocalypseangel2 |
1. | chae69933 | |
2. | heyjosh | |
3. | brianpitkin | |
4. | howpilothero | |
5. | apocalypseangel2 |
1. | heyjosh 01/03/2018 Five Prime Therapeutics Submits Investigational New Drug Application for Novel B7-H4 Antibody FPA150 |
2. | chae69933 02/28/2018 Yep :) {Image} |
3. | chae69933 01/25/2018 Five Prime Therapeutics announced that a development milestone for cabiralizumab has been achieved |
4. | chae69933 01/25/2018 Prices upsized underwritten public offering |
5. | chae69933 02/27/2018 Beats EPS loss estimates range from $0.27-$0.36. Misses on revenues. |
6. | chae69933 01/23/2018 News out for $FPRX: |